Skip to main content
. 2016 Sep 17;7(46):75185–75196. doi: 10.18632/oncotarget.12092

Table 1. Expression of miRNA-424-5p expression and Smad3 in human gastric cancer according to patients' clinicopathological characteristics.

Characteristics Number (%) miR-424-5p expression P-value Smad3 expression P-value
High group Low group High group Low group
Age(years)
 <60 18 7 11 0.380 10 8 0.425
 ≥60 45 23 22 20 25
Gender
 Male 29 16 13 0.268 14 15 0.023
 Female 34 14 20 16 18
Size(cm)
 <3 30 9 21 0.008* 20 10 0.004*
 ≥3 33 21 12 10 23
Histology grade
 Well-moderately 19 11 8 0.283 10 9 0.601
 Poorly-signet 44 19 25 20 24
stage
 I/II 22 9 13 0.435 8 14 0.190
 III/IV 41 21 20 22 19
T grade
 T1+T2 20 8 12 0.058 7 13 0.171
 T3+T4 43 22 21 23 20
Lymph node metastasis
 Present (N1-N3) 40 22 18 0.122 16 24 0.110
 Absent(N0) 23 8 15 14 9
*

p<0.05 Statistically significant difference